Most information about stroke in Aboriginal/ Torres Strait Islander (Aboriginal) Australians comes from State hospital databases; data quality varies. Alice Springs Hospital is the sole hospital serving a large catchment in which 27% of inhabitants are Aboriginal people. It is ideally suited to the aim of this study, namely to compare stroke subtypes and outcomes between Aboriginal and non-Aboriginal people.
Background and aim:
Most information about stroke in Aboriginal/ Torres Strait Islander (Aboriginal) Australians comes from State hospital databases; data quality varies. Alice Springs Hospital is the sole hospital serving a large catchment in which 27% of inhabitants are Aboriginal people. It is ideally suited to the aim of this study, namely to compare stroke subtypes and outcomes between Aboriginal and non-Aboriginal people.
Methods:
We examined medical records of all Alice Springs Hospital stroke admissions (2011 ( -2014 . Data were extracted using a pre-specified template. Clinical and radiological information was examined to assign a final stroke and aetiological classification.
Results: Of 141 residents of Alice Springs admitted to hospital with first ever stroke during the study period, 58% were identified as Aboriginal. Stroke occurred in Aboriginal people at a younger age (mean 56.4 years) than non-Aboriginal people (mean 68.6 years, P < 0.001). Agestandardised stroke incidence was greater in Aboriginal people (172, than non-Aboriginal people (44, 95% CI 31-57; incidence rate ratio (IRR) 3.9, 95% CI 2.8-5.6), similarly in men and women.
In those aged <55 years, stroke incidence was five-fold higher in Aboriginal people than non-Aboriginal people (5.13, 95% CI 2.37-12.66). Incidence of intracerebral haemorrhage in Aboriginal people was particularly excessive (IRR 6.7, ). Mortality was non-significantly higher (20% vs 8%, P = 0.085).
Conclusion:
Stroke incidence rates in Aboriginal people are excessive and occur at younger ages than non-Aboriginal people, with particular excess in intracerebral haemorrhage. Further work is required to reduce disparities in the occurrence of stroke. Background: Demand for deceased donor kidneys has exceeded supply in Australia over the past two decades. With a desire to utilise as many donor organs as possible, the health characteristics of accepted donors may have changed over time.
TEMPORAL CHANGES IN DECEASED KIDNEY DONOR CHARACTERISTICS IN AUSTRALIA
Aim: Kidneys from deceased donors in Australia are allocated on waiting time and human leukocyte antigen matching, without consideration of donor kidney quality. It has been observed that the spectrum of deceased donor kidney quality in Australia has become broader over time because of expanding donor age, co-morbidity and mode of donor death. The aim of this study was to describe the temporal changes in Australian donor characteristics between 1994 and 2013.
Methods: All deceased kidney donors actually transplanted in Australia between 1 January 1994 and 31 December 2013 were retrospectively analysed, using data from the Australian and New Zealand Organ Donor Registry.
Results: Of 4173 deceased donors, 58% were male. Mean donor age increased from 35.4 AE 16.6 years to 46.5 AE 17.5 years over time, and donor numbers increased from 149 in 1994 to 332 in 2013. As the primary cause of death, motor vehicle accidents decreased from 20% to 6% whereas cerebral pathology persisted at 50%. There was an increase in the proportion of donors with hypertension (11.4-23%), diabetes (1-6%) and an increase in mean body mass index (24.4 AE 4.4 to 27.5 AE 6.3 kg/m 2 ) between 1994 and 2013. These changes were reflected by an increase in the median kidney donor risk index from 0.98 AE 0.29 to 1.24 AE 0.42 (P < 0.001).
Conclusions:
As deceased kidney donor numbers have increased, the range of donor quality has broadened, with an increase in both the proportion and number of high-risk donors, as well as a decline in donor quality. This highlights the need for kidney allocation algorithms to evolve to ensure appropriate allocation of deceased donor kidneys. Introduction: Patients presenting with primary hyperparathyroidism have one of the three possible histopathological diagnoses: (i) parathyroid hyperplasia, (ii) parathyroid adenoma and (iii) parathyroid carcinoma. Each of these requires different surgical approaches: (i) removal of 3.5 glands, (ii) removal of adenoma and (iii) removal of carcinoma plus ipsilateral neck dissection respectively. Therefore, intraoperative pathology consultation plays a key role in parathyroidectomy. Telepathology, where the slide is interpreted off-site through dedicated telepathology robotic systems, may overcome some of the logistical difficulties traditionally associated with in-house microscopy for frozen section interpretation, for example availability of a local surgical pathologist, travelling time and time spent waiting for surgeons to provide specimens.
REMOTE FROZEN SECTION EXAMINATION OF PARATHYROIDECTOMY SPECIMENS BY TELEPATHOLOGY USING MIKROSCAN D2 AND APERIO LV1: A VALIDATION STUDY

Aim:
The aim of this study is to validate two robotic telepathology (RT) systems (Aperio LV1 and Mikroscan D2) for parathyroid frozen section diagnosis. To do this, we compared the diagnostic accuracy and speed taken to make a diagnosis through the two RT systems with inhouse frozen section diagnosis through microscopy.
Methods: Three pathology services in Sydney (Austpath Laboratories, SWAPS and ICPMR) each submitted 20 consecutive parathyroidectomy cases with frozen section specimens to the study. This resulted in a total of 60 cases, with 84 slides. Three pathologists (EC, LS and SC) interpreted these cases: first with the Aperio LV1 system, then with the Mikroscan D2 system and finally with in-house microscopy. Each pathologist had a 2-week washout period between the three systems. We recorded the diagnoses and the time taken to arrive at the diagnosis.
Results: Aperio LV1 had a slightly higher rate of concordant diagnoses with in-house microscopy compared to Mikroscan D2 for pathologists EC (92.9% vs 90.5%) and LS (95.2% vs 94.7%). We recorded a lower rate of concordant diagnoses for pathologists SC/MF with Aperio LV1 compared to Mikroscan D2 (79.8% vs 88.1%). This may have been due to interobserver variability in addition to inter-method variability, as SC interpreted the slide set with in-house microscopy and Mikroscan D2, while MF completed the slide set with Aperio LV1. Average slide interpretation time was 35.9 s for in-house microscopy, 94.4 s for Aperio LV1 and 232.5 s for Mikroscan D2.
